- Home
- UBS vs SYK Comparison
UBS vs SYK Comparison
Compare UBS & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBS
- SYK
- Stock Information
- Founded
- UBS 1862
- SYK 1941
- Country
- UBS Switzerland
- SYK United States
- Employees
- UBS N/A
- SYK N/A
- Industry
- UBS Major Banks
- SYK Medical/Dental Instruments
- Sector
- UBS Finance
- SYK Health Care
- Exchange
- UBS Nasdaq
- SYK Nasdaq
- Market Cap
- UBS 122.4B
- SYK 142.6B
- IPO Year
- UBS N/A
- SYK N/A
- Fundamental
- Price
- UBS $39.53
- SYK $377.57
- Analyst Decision
- UBS Buy
- SYK Buy
- Analyst Count
- UBS 3
- SYK 19
- Target Price
- UBS N/A
- SYK $427.67
- AVG Volume (30 Days)
- UBS 2.0M
- SYK 1.3M
- Earning Date
- UBS 07-30-2025
- SYK 07-31-2025
- Dividend Yield
- UBS 1.88%
- SYK 0.89%
- EPS Growth
- UBS 232.88
- SYK N/A
- EPS
- UBS 1.89
- SYK 7.55
- Revenue
- UBS $47,011,000,000.00
- SYK $23,818,000,000.00
- Revenue This Year
- UBS $1.93
- SYK $10.75
- Revenue Next Year
- UBS $2.79
- SYK $8.35
- P/E Ratio
- UBS $19.96
- SYK $50.00
- Revenue Growth
- UBS 1.24
- SYK 11.36
- 52 Week Low
- UBS $25.75
- SYK $320.78
- 52 Week High
- UBS $39.71
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- UBS 72.60
- SYK 39.35
- Support Level
- UBS $35.94
- SYK $373.72
- Resistance Level
- UBS $38.30
- SYK $381.34
- Average True Range (ATR)
- UBS 0.43
- SYK 6.80
- MACD
- UBS 0.02
- SYK -2.64
- Stochastic Oscillator
- UBS 95.23
- SYK 16.13
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.